A child has been prescribed to begin treatment with somatropin for growth deficiency. His mom asks how long he will need to take this medication.
What is the nurse’s best response?
He will stop taking this medication once his growth plates fuse.
This medication is intended for life-long treatment.
Most people need this medication for 2-3 months until they reach their weight goal.
10 days is the maximum time someone can be on this medication.
The Correct Answer is A
Choice A reason: This is correct. Somatropin is a synthetic form of human growth hormone (HGH), which stimulates the growth of bones and tissues. It is used to treat growth deficiency in children who have low or no natural HGH. The treatment is usually stopped when the growth plates (the areas of cartilage at the ends of the long bones) fuse, which marks the end of the growth period. This usually occurs around the age of 14-18 years for boys and 12-16 years for girls.
Choice B reason: This is incorrect. Somatropin is not intended for life-long treatment. It is only used to correct growth deficiency in children who have low or no natural HGH. Once the growth plates fuse, the treatment is discontinued.
Choice C reason: This is incorrect. Somatropin is not used for weight management. It is used to treat growth deficiency in children who have low or no natural HGH. The duration of the treatment depends on the individual growth potential and response to the medication, not on the weight goal.
Choice D reason: This is incorrect. Somatropin is not a short-term medication. It is used to treat growth deficiency in children who have low or no natural HGH. The treatment usually lasts for several years, until the growth plates fuse.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A reason: This is correct because high lipid levels, such as cholesterol and triglycerides, are a risk factor for cardiovascular disease. HMG-CoA reductase inhibitors, also known as statins, lower the production of cholesterol in the liver and reduce the risk of heart attack and stroke.
Choice B reason: This is incorrect because blood glucose of 60 is not related to the need for an HMG-CoA reductase inhibitor. Blood glucose of 60 is below the normal range and may indicate hypoglycemia, which is a low blood sugar level. Hypoglycemia can cause symptoms such as dizziness, confusion, sweating, and hunger.
Choice C reason: This is incorrect because platelets over 150,000 are not related to the need for an HMG-CoA reductase inhibitor. Platelets are blood cells that help with clotting and prevent bleeding. The normal range of platelets is 150,000 to 450,000 per microliter of blood. Platelets over 150,000 are within the normal range and do not indicate a problem.
Choice D reason: This is incorrect because low INR is not related to the need for an HMG-CoA reductase inhibitor. INR stands for international normalized ratio and is a measure of how long it takes the blood to clot. The normal range of INR is 0.8 to 1.2. Low INR means the blood clots faster than normal and may indicate a risk of thrombosis, which is a blood clot in a vein or artery.
Correct Answer is C
Explanation
Choice A reason: Diet cola PO is not an appropriate recommendation for a client with a blood glucose of 30, because diet cola does not contain any sugar and will not raise the blood glucose level. Moreover, the client is lethargic and unable to follow commands, which means they may have difficulty swallowing and may aspirate the liquid.
Choice B reason: Dextrose 50% IV is a potential recommendation for a client with a blood glucose of 30, because it can rapidly increase the blood glucose level and reverse the symptoms of hypoglycemia. However, the nurse is unable to get an IV line started on the client, which makes this option impossible.
Choice C reason: Glucagon IM is the best recommendation for a client with a blood glucose of 30, because it can stimulate the liver to release glucose into the bloodstream and raise the blood glucose level. Glucagon can be given intramuscularly or subcutaneously, which does not require an IV access. Glucagon is usually given as an emergency treatment for severe hypoglycemia when the client is unconscious or unable to swallow.
Choice D reason: Insulin glargine SQ is not an appropriate recommendation for a client with a blood glucose of 30, because insulin glargine is a long-acting insulin that lowers the blood glucose level. Giving insulin to a client with hypoglycemia can worsen their condition and cause coma or death. ⁹
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.